Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease
Objective: To characterize life course sleep duration trajectories and examine their associations with PD risk and age at onset (AAO). Background: Sleep disturbances could be…Lung Function and the Risk of Parkinson’s Disease: A Population-based Cohort Study
Objective: The study aims to explore the association between lung function and the risk to develop PD. Background: Some researchers have noted a faster decline…Prevalence, demographic characteristics of Parkinson disease and associated comorbidities: An analysis of the Colombian Ministry of Health official registry
Objective: Conduct a descriptive analysis of the Colombian Parkinson’s disease population and its comorbidities using data from the Colombian Ministry of Health.Estimate the prevalence and…Levodopa response in pathology-confirmed Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy
Objective: to describe the rate of levodopa response, phenotypical characteristics, prognostic implications and pathological features in a large cohort of patients with pathology-confirmed Parkinson’s disease…The Impact of Freezing of Gait on Falls over time in Parkinson’s disease
Objective: To quantify falls related to Freezing of Gait (FoG) versus unrelated to FoG as Parkinson’s disease progresses. Background: FoG is a debilitating symptom of…Evaluation of Effects of Levodopa and Subthalamic Nucleus Stimulation (STN-DBS) on Gait using Quantified Timed Up and Go Test in People with Parkinson’s Disease (PD)
Objective: This study evaluates effect of medication and stimulation on transfers and gait in people with PD post STN-DBS using an automated, quantitative assessment involving…Parkinson’s Disease Diagnosed in a Patient with Anti-Musk Positive Myasthenia Gravis: Coincidence? – Case Report and Literature Review
Objective: To describe a case of a male patient presenting with anti-Musk positive Myasthenia Gravis (MG) and Parkinson's Disease (PD) with an adequate response to…A Registry for Sleep and Circadian Health Quality in Parkinson’s Disease (ReSCQu-PD)
Objective: To characterize sleep-, circadian- and disease-related factors contributing to daytime sleepiness in a cohort of people with Parkinson’s Disease (PwPD). Background: Excessive daytime sleepiness…PINK1 activation improves outcomes in the UQCRC1 models of Parkinson’s disease
Objective: To investigate the role of chronic oxidative phosphorylation (OXPHOS) stress in mitophagy and the therapeutic potential of PINK1 activation in the UQCRC1 models of…Profiling Neural Protein Dopaminylation in Parkinson’s disease
Objective: The hallmark of Parkinson’s Disease is motor dysfunction from the decline in dopaminergic cells in the substantia nigra (SN), leading to the development of…
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 436
- Next Page »